199 related articles for article (PubMed ID: 20206292)
1. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic and carcinogenic effects of gastrointestinal drugs.
Brambilla G; Mattioli F; Martelli A
Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity and carcinogenicity studies of antihistamines.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Arch Toxicol; 2011 Oct; 85(10):1173-87. PubMed ID: 21327970
[TBL] [Abstract][Full Text] [Related]
5. Genotoxic and carcinogenic effects of antipsychotics and antidepressants.
Brambilla G; Mattioli F; Martelli A
Toxicology; 2009 Jul; 261(3):77-88. PubMed ID: 19410629
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
[TBL] [Abstract][Full Text] [Related]
7. Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutat Res; 2012; 750(1):1-51. PubMed ID: 21968027
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity and carcinogenicity studies of benzodiazepines.
Brambilla G; Carrozzino R; Martelli A
Pharmacol Res; 2007 Dec; 56(6):443-58. PubMed ID: 17920927
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
10. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
Brambilla G; Martelli A
Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
[TBL] [Abstract][Full Text] [Related]
12. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
Brambilla G; Martelli A
Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
Kirkland D; Speit G
Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
[TBL] [Abstract][Full Text] [Related]
14. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
16. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity.
Snyder RD
Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
18. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals.
Van Deun K; Van Cauteren H; Vandenberghe J; Canning M; Vanparys P; Coussement W
Adverse Drug React Toxicol Rev; 1997 Nov; 16(4):215-33. PubMed ID: 9608857
[TBL] [Abstract][Full Text] [Related]
19. In vitro carcinogenicity testing: present and future perspectives in pharmaceutical development.
Kowalski LA
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):29-35. PubMed ID: 11727320
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic and carcinogenic potential of menadione.
Cojocel C; Novotny L; Vachalkova A
Neoplasma; 2006; 53(4):316-23. PubMed ID: 16830059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]